[Dexamonosone as a rheuma therapeutic agent].
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001132:Arm; D001168:Arthritis / Q000188:drug therapy*; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D004304:Dosage Forms; D004893:Erythema Nodosum / Q000188:drug therapy; D005419:Flavonoids / Q000008:administration & dosage; D006073:Gout / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006615:Hip; D006801:Humans; D007717:Knee; D008012:Lidocaine / Q000008:administration & dosage; D008161:Lumbosacral Region; D009777:Occipital Bone; D010003:Osteoarthritis / Q000188:drug therapy*; D010653:Phenylbutazone / Q000008:administration & dosage; D010946:Plants, Medicinal / Q000187:drug effects; D012457:Salicylamides / Q000008:administration & dosage; D012782:Shoulder; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013909:Thorax; D013924:Thrombophlebitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D004304:Dosage Forms; D005419:Flavonoids; D012457:Salicylamides; D008012:Lidocaine; D010653:Phenylbutazone
Dexamonozon als Rheuma-Therapeutikum.